Clovis Oncology reported $-67410000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Anika Therapeutics ANIK:US $ 0.56M 5.97M
Arrowhead Research ARWR:US $ -63374000 33.45M
Astrazeneca AZN:US $ -1652M 2202M
AstraZeneca AZN:LN -1652M 2202M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
GlaxoSmithKline GSK:LN 1168M 227M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Halozyme Therapeutics HALO:US $ 216.59M 125.13M
Insmed INSM:US $ -112714000 4.61M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Merk MRK:US $ 4567M 3022M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novartis NOVN:VX SF 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Seattle Genetics SGEN:US $ -293.85M 209.27M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Veracyte VCYT:US $ -14.13M 5.09M
YTE INCY:US $ 181.74M 32.28M